• 10/31/24

Introduction To The Stem Cell Harvesting & Banking Clinical Trial

Dr. Chitra Hosing shares details on this clinical trial, sponsored by RRP at MD Anderson Cancer Center, which aims to evaluate the safety and feasibility of collecting and banking blood stem cells from RUNX1-FPD patients.

Hereditary Hematologic Malignancies: Not That Rare

Neoplasias Hematológicas Hereditarias: No Tan Poco Frecuentes (September 2024)

You Might Also Like

Related Embedded Video Item Thumbnail Hematopoietic stem cell division is governed by distinct RUNX1 binding partners
Related Embedded Video Item Thumbnail Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML
Related Embedded Video Item Thumbnail Part 2: April 2025 Sirolimus Study Update Patient Participants Perspectives and Q&A
Related Embedded Video Item Thumbnail Hereditary Hematologic Malignancies: Not That Rare
Related Embedded Video Item Thumbnail Limiting Cancer Risk Through Physical Activity